Mizuho MedyLtd Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Fuminari Karakawa

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	47yrs
CEO sahipliği	36.7%
Yönetim ortalama görev süresi	14.6yrs
Yönetim Kurulu ortalama görev süresi	12.7yrs

Son yönetim güncellemeleri

Recent updates

Mizuho Medy Co.,Ltd.'s (TSE:4595) Earnings Are Not Doing Enough For Some Investors

Aug 06

CEO

Fuminari Karakawa (79 yo)

47yrs

Görev süresi

Mr. Fuminari Karakawa founded MIZUHO MEDY Co., Ltd. in November 1977 and serves as its President and Representative Director since November 1977. Mr. Karakawa serves as the Chairman of the Board at MIZUHO...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fuminari Karakawa	Chairman of the Board & President	47yrs	Veri yok	36.69% ¥ 11.1b
Hiroshi Sasaki	GM of Accounting Department & General Affairs Department and Director	14.6yrs	Veri yok	0.22% ¥ 65.4m
Toshio Kamihara	General Manager of Sales Division & Overseas Business Department and Director	9.7yrs	Veri yok	0.074% ¥ 22.3m
Tadashi Imamura	MD, Technology Supervisor	no data	Veri yok	0.43% ¥ 130.9m
Kazuhiro Ichimaru	Manager of Intellectual Property Department & Director	no data	Veri yok	0.48% ¥ 145.7m
Kenji Narahara	Manager of Development Department and Director	no data	Veri yok	0.54% ¥ 162.7m

14.6yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim: 4595 'un yönetim ekibi deneyimli ve deneyimlidir ( 14.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fuminari Karakawa	Chairman of the Board & President	47yrs	Veri yok	36.69% ¥ 11.1b
Hiroshi Sasaki	GM of Accounting Department & General Affairs Department and Director	13.7yrs	Veri yok	0.22% ¥ 65.4m
Toshio Kamihara	General Manager of Sales Division & Overseas Business Department and Director	9.7yrs	Veri yok	0.074% ¥ 22.3m
Tadashi Imamura	MD, Technology Supervisor	14.7yrs	Veri yok	0.43% ¥ 130.9m
Kazuhiro Ichimaru	Manager of Intellectual Property Department & Director	13.7yrs	Veri yok	0.48% ¥ 145.7m
Kenji Narahara	Manager of Development Department and Director	11.7yrs	Veri yok	0.54% ¥ 162.7m
Katsumi Sasaki	Independent External Director	9.7yrs	Veri yok	0.028% ¥ 8.5m
Nobuhiko Shigemi	External Auditor	13.7yrs	Veri yok	0.019% ¥ 5.8m
Takakichi Hashimoto	External Auditor	9.7yrs	Veri yok	0.021% ¥ 6.2m
Hirotaka Kawasaki	Chairman of Board of Corporate Auditors	5.7yrs	Veri yok	0.34% ¥ 102.9m

12.7yrs

Ortalama Görev Süresi

64.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 4595 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 12.7 yıldır).

Mizuho MedyLtd Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 28, 2024

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 29, 2023

No independent directors

No independent directors

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 30, 2022

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 26, 2021

Recent updates

Mizuho Medy Co.,Ltd. has filed a Follow-on Equity Offering.

Mizuho Medy Co.,Ltd. has filed a Follow-on Equity Offering.

Third quarter 2024 earnings released: EPS: JP¥27.85 (vs JP¥143 in 3Q 2023)

Mizuho Medy Co.,Ltd. to Report Q3, 2024 Results on Nov 08, 2024

Second quarter 2024 earnings released: EPS: JP¥54.49 (vs JP¥75.07 in 2Q 2023)

Mizuho Medy Co.,Ltd.'s (TSE:4595) Earnings Are Not Doing Enough For Some Investors

Upcoming dividend of JP¥80.00 per share

Mizuho Medy Co.,Ltd. to Report Q2, 2024 Results on Aug 09, 2024

First quarter 2024 earnings released: EPS: JP¥102 (vs JP¥78.33 in 1Q 2023)

Mizuho Medy Co.,Ltd. to Report Q1, 2024 Results on May 10, 2024

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 28, 2024

Full year 2023 earnings released: EPS: JP¥396 (vs JP¥823 in FY 2022)

Now 21% undervalued

Inaugural dividend of JP¥140 per share

Mizuho Medy Co.,Ltd. to Report Q4, 2023 Results on Feb 09, 2024

Third quarter 2023 earnings released: EPS: JP¥143 (vs JP¥308 in 3Q 2022)

Investor sentiment improves as stock rises 16%

Mizuho Medy Co.,Ltd. to Report Q3, 2023 Results on Nov 10, 2023

Investor sentiment improves as stock rises 19%

Price target decreased by 23% to JP¥2,400

Second quarter 2023 earnings released: EPS: JP¥75.07 (vs JP¥135 in 2Q 2022)

Mizuho Medy Co.,Ltd. to Report Q2, 2023 Results on Aug 10, 2023

Inaugural dividend of JP¥40.00 per share

First quarter 2023 earnings released: EPS: JP¥78.33 (vs JP¥201 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥823 (vs JP¥506 in FY 2021)

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 29, 2023

Mizuho Medy Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 10, 2023

Inaugural dividend of JP¥160 per share

Price target decreased to JP¥2,500

No independent directors

Third quarter 2022 earnings released: EPS: JP¥308 (vs JP¥187 in 3Q 2021)

Mizuho Medy Co.,Ltd. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥135 (vs JP¥173 in 2Q 2021)

Investor sentiment improved over the past week

Inaugural dividend of JP¥50.00 per share

Mizuho Medy Co.,Ltd. to Report Q2, 2022 Results on Aug 10, 2022

First quarter 2022 earnings released: EPS: JP¥201 (vs JP¥68.35 in 1Q 2021)

No independent directors

Mizuho Medy Co.,Ltd. to Report Q1, 2022 Results on May 09, 2022

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 30, 2022

Inaugural dividend of JP¥95.00 per share

Third quarter 2021 earnings released: EPS JP¥187 (vs JP¥8.29 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥173 (vs JP¥9.45 loss in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS JP¥68.35 (vs JP¥0.32 loss in 1Q 2020)

Full year 2020 earnings released: EPS JP¥32.13 (vs JP¥91.76 in FY 2019)

Mizuho Medy Co.,Ltd. to Report Q1, 2021 Results on May 10, 2021

New 90-day high: JP¥2,653

Full year 2020 earnings released: EPS JP¥32.13 (vs JP¥91.76 in FY 2019)

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 26, 2021

Investor sentiment improved over the past week

New 90-day high: JP¥1,565

First Dividend Is JP¥6.00 Per Share

Mizuho Medy Co.,Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

New 90-day low: JP¥1,307

Price target raised to JP¥1,500

Mizuho Medy Co.,Ltd. to Report Q3, 2020 Results on Nov 09, 2020

Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş